Latest Healthcare Research Reports

Tag: blood plasma derivatives market report

  • Blood Plasma Derivatives Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities

    Blood Plasma Derivatives Market Analysis: Key Insights on Growth Rates, Trends, and Major Opportunities

    Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

    How has the blood plasma derivatives market grown in recent years?

    The size of the blood plasma derivatives market has been expanding robustly in the past years. The market, which is poised to surge from $51.81 billion in 2024 to $56.24 billion in 2025, will record a compound annual growth rate (CAGR) of 8.6%. Factors that have prompted growth during the historic period include the escalating prevalence of hemophilia and bleeding disorders, an increase in the elderly population, enhanced awareness and diagnosis, a surge in surgical procedures, and the growth of global blood transfusion services.

    How is the blood plasma derivatives market size expected to evolve during the forecast period?

    The market for blood plasma derivatives is set to experience robust expansion in the coming years, with its worth projected to reach $80.42 billion in 2029 at a compound annual growth rate (CAGR) of 9.4%. This predicted growth in the forecast phase can be accredited to the rise of therapies for rare diseases, an increase in chronic illnesses, amplified healthcare expenditure, patient-focused treatment methodologies, and the expansion of healthcare infrastructure. Key trends anticipated during the forecast period consist of progress in fractionation technologies, patient-focused strategies, collaborations and partnerships, growing uses in the field of neurology, and technological breakthroughs in plasma fractionation.

    Get your blood plasma derivatives market report here!

    https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

    Which key drivers are propelling the blood plasma derivatives market’s growth?

    The growth of the blood plasma derivatives market is anticipated to be propelled by the rising occurrence of immunodeficiency disorders. These diseases either completely or partially impair the immune system. Blood plasma derivatives are extensively employed in the treatment of a host of medical conditions, including immune deficiency disorders. Plasma, which is a mixture of proteins and salts, contains over 100 different proteins. Among these, immunoglobulins are specifically used for managing primary immunodeficiencies. Malnutrition or insufficient nutrition causes deficiencies in macro and micronutrients, leading to immunodeficiency. For example, the Allergy, Asthma & Clinical Immunology reported in March 2022 that the most frequent disorder was Common Variable Immunodeficiency (CVID), affecting 16.6% of individuals in the US, 12.9% internationally, and 13.9% globally. Hence, the escalating prevalence of immune deficiency disorders is fueling the growth of the blood plasma derivatives market.

    What are the market segments in the blood plasma derivatives industry?

    The blood plasma derivatives market covered in this report is segmented –

    1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types

    2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other Applications

    3) By End-User: Hospitals, Clinics, Other End-Users

    Subsegments:

    1) By Albumin: Human Serum Albumin, Recombinant Albumin

    2) By Factor VIII: Plasma-Derived Factor VIII, Recombinant Factor VIII

    3) By Factor IX: Plasma-Derived Factor IX, Recombinant Factor IX

    4) By Immunoglobulin: Intravenous Immunoglobulin (IVIG), Subcutaneous Immunoglobulin (SCIG)

    5) By Hyperimmune Globulin: Specific Pathogen-Reduced Hyperimmune Globulin, Standard Hyperimmune Globulin

    6) By Other Types: Fibrinogen, Clotting Factor Concentrates, Plasma-Derived Proteins

    Get your free sample now – explore exclusive market insights:

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

    Which leading companies are shaping the growth of the blood plasma derivatives market?

    Major companies operating in the blood plasma derivatives market include Bayer AG, Sanofi S.A., Takeda Pharmaceutical Company Limited, Baxter International Inc., CSL Limited, Meiji Group, Grifols S.A., Shire Pharmaceuticals Inc., GC Biopharma Corp, Emergent BioSolutions Inc., Shanghai Raas Blood Products Co Ltd., Kedrion S.p.A., Sanquin, Biotest AG, Bio Products Ltd., ADMA Biologics Inc., China Biologic Products Holdings Inc., BioIVT, PlasmaGen BioSciences Pvt. Ltd., Virchow Biotech Private Limited, LFB S.A., Intas Pharmaceuticals Ltd., Octapharma Plasma

    What key trends are currently impacting the blood plasma derivatives market’s development?

    Major players in the blood plasma derivatives market are concentrating on forming strategic alliances to secure a competitive position. This collaboration ensures that patients have a reliable, consistent source of essential plasma-derived medications, addressing the growing demand for immunoglobulins both in France and globally. For example, in January 2022, Kedrion S.p.A., a biopharmaceutical company from Italy that focuses on developing, manufacturing, and distributing plasma-derived therapies, formed a partnership with LPB, a UK-based company that specializes in biological medicinal products. Kedrion will process LFB plasma, acquired in France by the Etablissement Français du Sang (EFS), in Hungary to create immunoglobulins. The existing immunoglobulin supply, which is provided to hospitals nationwide, monitored and guided by French health authorities, will be bolstered by these imports from LFB in France.

    Unlock exclusive market insights – purchase your research report now for a swift delivery!

    https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12107

    Which geographic areas are influencing the growth of the blood plasma derivatives market?

    North America was the largest region in the blood plasma derivatives market in 2024. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    Browse Through More Similar Reports By The Business Research Company:

    Electrolyte Mixes Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/electrolyte-mixes-global-market-report

    Blood Group Typing Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report

    Hemostasis Analyzers Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/hemostasis-analyzers-global-market-report

    About The Business Research Company:

    With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Insights into the Blood Plasma Derivatives Market’s Growth Opportunities for 2024-2033

    Key Insights into the Blood Plasma Derivatives Market’s Growth Opportunities for 2024-2033

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Estimated Growth Rate for the Blood Plasma Derivatives Market Between 2024 and 2033?

    In the past few years, there has been a significant increase in the size of the blood plasma derivatives market. It is predicted to expand from $48.26 billion in 2023 to $52.61 billion in 2024, demonstrating a compound annual growth rate (CAGR) of 9.0%. Factors contributing to this growth during the historic period include an increased occurrence of hemophilia and bleeding disorders, a rise in the elderly population, greater awareness and diagnosis, a surge in surgical procedures and worldwide blood transfusion services.

    The market size for blood plasma derivatives is projected to experience significant expansion in the coming years, and it is anticipated to reach $75 billion by 2028, with a compound annual growth rate (CAGR) of 9.3%. Factors contributing to this projected growth during the forecasted period include the development of therapies for rare diseases, an increase in chronic illnesses, rising healthcare spending, patient-focused treatment methodologies, and the expansion of healthcare infrastructure. Key trends during this period are expected to involve progress in fractionation technologies, patient-oriented strategies, collaborations and partnerships, widened neurological applications, and technological advancements in plasma fractionation.

    Claim Your Free Sample of the Global Blood Plasma Derivatives Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=12107&type=smp

    What Are the Primary Contributors to the Growth of the blood plasma derivatives Market?

    The blood plasma derivatives market is projected to experience growth due to the increasing occurrence of immunodeficiency disorders. These disorders, which impair the immune system either entirely or partially, can be treated using blood plasma derivatives. Plasma is a protein and salt solution that contains over 100 different proteins. Immunoglobulins, a type of these proteins, are significantly used to deal with primary immunodeficiencies. Inadequate or poor nutrition can lead to deficiencies in both macro and micronutrients, resulting in immunodeficiency. As indicated in a report released by the World Health Organization in July 2022, hunger affected 828 million people worldwide in 2021, and it is a major cause of malnutrition. Consequently, the growing incidence of immune deficiency disorders is propelling the expansion of the blood plasma derivatives market.

    Which Key Segments Comprise the Blood Plasma Derivatives Market?

    1) By Type: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types

    2) By Application: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other Applications

    3) By End-User: Hospitals, Clinics, Other End-Users

    What Are the Key Trends Reshaping the Blood Plasma Derivatives Market?

    Major firms active in the blood plasma derivatives market are taking strategic partnership steps to secure a competitive advantage. Such collaborations ensure a stable and reliable flow of essential plasma-derived medicines to those in need, addressing the growing demand for immunoglobulins both in France and internationally. To illustrate, in January 2022, the Italy-based Kedrion S.p.A., a biopharmaceutical organization skilled in developing, manufacturing, and distributing plasma-derived therapies, joined forces with LPB, a UK-based pharmaceutical firm known for its work with biological medicinal products. Kedrion’s immunoglobulin production in Hungary will utilize LFB plasma from France, provided by the Etablissement Français du Sang (EFS). This new influx of immunoglobulins from LFB in France will boost the existing supply, under the watchful eye of French health authorities, and will be distributed to hospitals nationwide.

    Order Now for Fast Delivery of Your Blood Plasma Derivatives Market Report!

    https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

    What Are the Top Regions Fueling Growth in the Blood Plasma Derivatives Market?

    North America was the largest region in the blood plasma derivatives market in 2023. The regions covered in the blood plasma derivatives market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Blood Plasma Derivatives Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the blood plasma derivatives market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Blood Plasma Derivatives Market Include

    1. Blood Plasma Derivatives Market Executive Summary

    2. Blood Plasma Derivatives Market Segments

    3. Blood Plasma Derivatives Market Size And Template Market Growth Rate

    4. Key Blood Plasma Derivatives Market Trends

    5. Major Blood Plasma Derivatives Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Blood Plasma Derivatives Market

    26. Top Blood Plasma Derivatives Companies

    27. Blood Plasma Derivatives Market Opportunities And Strategies

    28. Blood Plasma Derivatives Market, Conclusions And Recommendations

    29. Appendix

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • What Is The Forecast Growth Rate For The Blood Plasma Derivatives Market?

    What Is The Forecast Growth Rate For The Blood Plasma Derivatives Market?

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    The Market’s Momentum: Growth Insights

    • Strong growth from $48.26 billion in 2023 to $52.61 billion in 2024.
    • Compound annual growth rate (CAGR) of 9.0% attributed to hemophilia, geriatric population, awareness, and surgical procedures.
    • Forecasted growth to $75 billion in 2028 with a CAGR of 9.3%.
    • Predicted factors: rare diseases therapies, chronic diseases, healthcare expenditure, patient-centric treatment, and healthcare infrastructure.

    Surging Demand for Blood Plasma Derivatives Driven by Immune Deficiency Disorders

    • Increasing prevalence of immunodeficiency disorders propels market growth.
    • Blood plasma derivatives crucial in treating immune deficiency conditions.
    • Example: Global hunger impacting malnutrition and immune deficiency.
    • Market players: Bayer, Sanofi, Takeda, Baxter, CSL, and others leading the charge.

    Read More On The Blood Plasma Derivatives Market Report 2024 – https://www.thebusinessresearchcompany.com/report/blood-plasma-derivatives-global-market-report

    Strategic Partnerships for Enhanced Access and Supply

    • Focus on strategic partnerships to ensure access and supply of immunoglobulins.
    • Example: Kedrion S.p.A. partners with LPB to produce immunoglobulins in Hungary using LFB plasma from France.
    • Partnerships aimed at meeting increasing demand for plasma-derived medications.

    Grifols S.A. Expands Product Line Through Biotest AG Acquisition

    • Grifols S.A. acquires Biotest AG to enhance plasma medicine availability.
    • Acquisition accelerates and expands product line, drives revenue growth.
    • Biotest AG contributes extensive European network of plasma facilities.
    • Example: Grifols S.A., a leader in plasma-derived medicines, expands its market presence.

    Segmenting the Market

    • Types: Albumin, Factor VIII, Factor IX, Immunoglobulin, Hyperimmune Globulin, Other Types.
    • Applications: Hemophilia, Hypogammaglobulinemia, Immunodeficiency Diseases, Von Willebrand’s Disease, Other Applications.
    • End-Users: Hospitals, Clinics, Other End-Users.

    Regional Dynamics

    • North America leads the market in 2023.
    • Regional trends influencing market dynamics.

    Conclusion: Pioneering Healthcare Solutions

    The blood plasma derivatives market emerges as a cornerstone in addressing immune deficiency disorders and advancing healthcare solutions globally. With strategic partnerships, acquisitions, and technological advancements, companies are poised to meet the increasing demand for plasma-derived medications. As the prevalence of chronic diseases rises and healthcare expenditure increases, the market continues to expand, driven by patient-centric approaches and advancements in healthcare infrastructure. Through collaboration and innovation, the future of blood plasma derivatives promises to revolutionize treatment approaches, ensuring improved patient outcomes and quality of life worldwide. As we embark on this journey, the blood plasma derivatives market stands at the forefront of healthcare innovation, shaping a healthier and more resilient future for all.

    Request for A Sample Of The Global Blood Plasma Derivatives Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=12107&type=smp